The global cardiovascular monitoring and diagnostic devices market is differentiated into six segments based on the product type. This section of report comprises of market revenue from 2011 to 2019.
Albany, NY -- (SBWIRE) -- 07/18/2016 -- In recent years, across the world, a large population has been diagnosed with heart diseases such as peripheral artery diseases, congenital heart diseases, coronary artery diseases, and pulmonary conditions. These have been particularly observed to be prevalent in high numbers in countries that are enjoying the gains of recently acquired economic development. In these countries, in the bid to develop robust welfare programs, preventive healthcare programs are gaining traction. These include programs for heart diseases, diabetes, and obesity. Thus, cardiovascular monitoring and diagnostic devices are in high demand in these countries.
Get Free Sample Report Brochure PDF:http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2385
Generally, in all parts of the world, the demand for cardiovascular monitoring and diagnostic devices is rising so as to better understand the functioning of the heart in patients with hypertension, diabetes, and obesity. Early diagnosis helps to offset the risk of heart conditions for these patients to some extent. In addition, with technology advancing at an unprecedented pace, devices that can be transported over long distances are stimulating the demand for cardiovascular monitoring and diagnostic devices.
By product, ECG systems, cardiovascular diagnostic catheters, ECG management systems, event monitors, Holter monitors, and implantable loop recorders are the segments of the market. Of these, in 2012, ECG systems accounted for the largest share in the global market. The easy compatibility of cardiovascular monitoring devices with ECG systems is the reason for this. In addition, the plummeting prices of ECG systems and ease of use of these systems for aging patients who have an increased risk of congestive heart failure will fuel the adoption of these devices in the coming years.
On the basis of geography, North America, Europe, Asia Pacific, and Rest of the World are the segmnets of the global market. Amongst all, in 2012, North America dominated the overall market due to a high level of awareness among patients about the availability of cutting-edge healthcare services. Moreover, in North America, faster adoption of advanced technology generally in all walks of life is the reason for the dominance of the region in the global market for cardiovascular monitoring and diagnostic devices.
However, Asia Pacific will exhibit an exponential CAGR in the cardiovascular monitoring and diagnostic devices market due to a few important reasons; these include: consistent improvement in healthcare infrastructure to serve unmet healthcare needs, increasing patient pool, and awareness about preventive healthcare due to skyrocketing healthcare costs.
Top companies that operate in the global cardiovascular monitoring and diagnostic devices market are GE Healthcare, Boston Scientific Corporation, Nihon Kohden Corporation, Welch Allyn Inc., Philips Healthcare, Siemens Healthcare, and St. Jude Medical Inc.
Browse Full Report With TOC:http://www.transparencymarketresearch.com/crdiovascular-monitoring-diagnostic-devices.html
About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street,
Albany NY - 12207
USA - Canada Toll Free: 866-552-3453